Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000351301 | SCV000362368 | uncertain significance | Hirschsprung Disease, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000399319 | SCV000362369 | uncertain significance | Renal hypodysplasia/aplasia 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307108 | SCV000362370 | uncertain significance | Multiple endocrine neoplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000366161 | SCV000362371 | uncertain significance | Pheochromocytoma | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988349 | SCV001138035 | likely benign | Multiple endocrine neoplasia type 2A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001453964 | SCV001657674 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002436139 | SCV002748141 | likely benign | Hereditary cancer-predisposing syndrome | 2021-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |